Sort

Search

16/08/2022 Diabetic retinopathy as a predictor of cardiovascular morbidity and mortality in subjects with type 2 diabetes
Barrot, J, Real, J, Vlacho, B, Romero-Aroca, P, Simo, R, Mauricio, D, Mata-Cases, M, Castelblanco, E, Mundet-Tuduri, X, Franch-Nadal, J. Diabetic retinopathy as a predictor of cardiovascular morbidity and mortality in subjects with type 2 diabetes. Frontiers in Medicine. 2022; 9DOI:10.3389/fmed.2022.945245. PMID:36052329. IF:3.900(Q2/4D).
13/08/2022 A comparison of front-line oral anticoagulants for the treatment of non-valvular atrial fibrillation: effectiveness and safety of direct oral anticoagulants in the FANTASIIA registry
Esteve-Pastor, MA, Rivera-Caravaca, JM, Ruiz-Ortiz, M, Muniz, J, Roldan-Rabadan, I, Otero, D, Lopez-Galvez, R, Cequier, A, Bertomeu-Martinez, V, Badimon, L, Anguita, M, Lip, GYH, Marin, F. A comparison of front-line oral anticoagulants for the treatment of non-valvular atrial fibrillation: effectiveness and safety of direct oral anticoagulants in the FANTASIIA registry. EXPERT OPINION ON PHARMACOTHERAPY. 2022; 23(12)DOI:10.1080/14656566.2022.2109961. PMID:35924672. IF:3.200(Q3/6D).
12/08/2022 An adapted scale to evaluate insight in Prader-Willi Syndrome
Cobo J., Coronas R., Pousa E., Oliva J.-C., Giménez-Palop O., Caixàs A.. An adapted scale to evaluate insight in Prader-Willi Syndrome. MEDICINA CLINICA. 2022; 159(3)DOI:10.1016/j.medcli.2021.07.015. PMID:34696903. IF:3.900(Q2/4D).
12/08/2022 Takotsubo syndrome and cancer, clinical and prognostic implications, insights of RETAKO (vol 155, pg 521, 2020)
Nunez-Gil, IJ, Vedia, O, Almendro-Delia, M, Raposeiras-Roubin, S, Sionis, A, Martin-Garcia, A, Martin-Garcia, A, Andres, M, Blanco, E, Martin-de-Miguel, I, Uribarri, A, Corbi-Pascual, M, Feltes, G, Bosch, X, Fabregat-Andres, O, Lopez-Pais, J, Sanchez-Grande-Flecha, A, Guillen-Marzo, M. Takotsubo syndrome and cancer, clinical and prognostic implications, insights of RETAKO (vol 155, pg 521, 2020). MEDICINA CLINICA. 2022; 159(3)DOI:10.1016/j.medcli.2022.03.001. PMID:35570030. IF:3.900(Q2/4D).